We are live on
!
Find out more
HS
HighVista Strategies Portfolio holdings
AUM
$362M
1-Year Est. Return
230.96%
This Fund
S&P 500
This Quarter
Est. Return
-3.48%
1 Year Est. Return
+230.96%
3 Year Est. Return
+518.4%
5 Year Est. Return
+644.94%
10 Year Est. Return
+2,223.31%
AUM
$195M
AUM Growth
+$72.8M
(+59%)
Cap. Flow
+$86.8M
Cap. Flow
% of AUM
44.43%
Top 10 Holdings %
Top 10 Hldgs %
56.45%
Holding
140
New
28
Increased
23
Reduced
31
Closed
32
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Dell
DELL
|
+$91.8M |
| 2 |
WCG
Wellcare Health Plans, Inc.
WCG
|
+$2.76M |
| 3 |
Innoviva
INVA
|
+$2.69M |
| 4 |
AGN
Allergan plc
AGN
|
+$2.55M |
| 5 |
Alibaba
BABA
|
+$2.54M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
MDCO
Medicines Co
MDCO
|
+$4.7M |
| 2 |
Biogen
BIIB
|
+$4.23M |
| 3 |
ARRS
ARRIS International plc Ordinary Shares
ARRS
|
+$2.92M |
| 4 |
IDTI
Integrated Device Technology I
IDTI
|
+$2.79M |
| 5 |
LXFT
Luxoft Holding, Inc.
LXFT
|
+$2.69M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 48.76% |
| 2 | Healthcare | 11.82% |
| 3 | Consumer Discretionary | 9.1% |
| 4 | Communication Services | 5.74% |
| 5 | Financials | 4.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Dell
DELL
$283B
| $75.8M | 38.79% |
+2,943,406
| New | +$91.8M |
|
2
Fox Class B
FOX
$20.7B
| $4.52M | 2.31% |
123,699
| – | – |
|
|
3
Alibaba
BABA
$269B
| $4.36M | 2.23% |
25,700
+14,700
| +134% | +$2.54M |
|
|
S
4
DELISTED
Sprint Corporation
S
| $4.34M | 2.22% |
661,157
| – | – |
|
5
Amazon
AMZN
$2.5T
| $3.79M | 1.94% |
40,000
| – | – |
|
6
TransDigm Group
TDG
$69.2B
| $3.77M | 1.93% |
7,800
| – | – |
|
7
Guidewire Software
GWRE
$11.5B
| $3.65M | 1.87% |
36,000
| – | – |
|
|
CELG
8
DELISTED
Celgene Corp
CELG
| $3.4M | 1.74% |
36,803
| – | – |
|
|
RP
9
DELISTED
RealPage, Inc.
RP
| $3.38M | 1.73% |
57,500
| – | – |
|
|
MDCO
10
DELISTED
Medicines Co
MDCO
| $3.3M | 1.69% |
90,409
-143,931
| -61% | -$4.7M |
|
11
Booking.com
BKNG
$138B
| $3.19M | 1.63% |
42,500
| – | – |
|
|
AGN
12
DELISTED
Allergan plc
AGN
| $3.09M | 1.58% |
+18,433
| New | +$2.55M |
|
|
FNSR
13
DELISTED
Finisar Corp
FNSR
| $2.99M | 1.53% |
130,661
| – | – |
|
|
RHT
14
DELISTED
Red Hat Inc
RHT
| $2.94M | 1.5% |
15,646
| – | – |
|
|
WCG
15
DELISTED
Wellcare Health Plans, Inc.
WCG
| $2.85M | 1.46% |
+10,008
| New | +$2.76M |
|
|
16
Innoviva
INVA
$1.58B
| $2.77M | 1.42% |
+189,941
| New | +$2.69M |
|
|
17
Biogen
BIIB
$29.9B
| $2.71M | 1.39% |
11,590
-18,319
| -61% | -$4.23M |
|
|
APC
18
DELISTED
Anadarko Petroleum
APC
| $2.63M | 1.35% |
37,240
+32,640
| +710% | +$2.19M |
|
|
MLNX
19
DELISTED
Mellanox Technologies, Ltd.
MLNX
| $2.55M | 1.3% |
23,013
| – | – |
|
|
ONCE
20
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
| $2.38M | 1.22% |
+23,271
| New | +$2.51M |
|
21
Ironwood Pharmaceuticals
IRWD
$611M
| $2.35M | 1.2% |
+214,932
| New | +$2.41M |
|
22
Pacific Biosciences
PACB
$422M
| $2.29M | 1.17% |
378,479
| – | – |
|
23
iShares MSCI India ETF
INDA
$6.71B
| $2.28M | 1.17% |
64,700
-4,600
| -7% | -$162K |
|
24
Vanguard Real Estate ETF
VNQ
$39.9B
| $2.19M | 1.12% |
24,999
| – | – |
|
25
Genworth Financial
GNW
$3.8B
| $2.14M | 1.1% |
578,000
| – | – |
|
Similar funds
SIAG
MS
WI
BHBT
WTFG
RC
VIA
A6
HighVista Strategies's Q2 2019 Portfolio in Review
As of Q2 2019, HighVista Strategies held 140 positions worth $195M, up 59% from $123M the previous quarter. Its ten largest holdings account for 56% of the portfolio.
HighVista Strategies deployed $86.8M of net new capital in Q2 2019, opening 28 new positions and adding to 23 existing holdings. Its largest new stake was Dell: 2,943,406 shares worth $75.8M.
By sector, the portfolio is most concentrated in Technology at 49% of assets, up from 17% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was Medicines Co, an estimated $4.7M trimmed.
- HighVista Strategies's largest Q2 2019 buy was Dell: 2,943,406 shares worth $75.8M.
- HighVista Strategies added most to Alibaba in Q2 2019, an estimated $2.54M increase.
- HighVista Strategies's biggest Q2 2019 reduction was Medicines Co, cutting an estimated $4.7M.
- HighVista Strategies fully exited ARRIS International plc Ordinary Shares in Q2 2019, selling an estimated $2.92M.
- HighVista Strategies's ten largest holdings make up 56% of its $195M portfolio in Q2 2019.
- HighVista Strategies opened 28 new positions and closed 32 in Q2 2019.
- HighVista Strategies's portfolio value rose 59% quarter-over-quarter to $195M.
Based on HighVista Strategies's 13F filing for Q2 2019, filed 14 Aug 2019.